Skip to main content

Table 1 Demographic and clinical characteristics of the study population

From: Target attainment and population pharmacokinetics of flucloxacillin in critically ill patients: a multicenter study

Characteristic

All patients (n = 31)

Male sex, %

58

Age, years

69 (54–76)

Height, cm, mean (SD)

172 (10)

ICU admission total body weight, kg

76 (64–85)

ICU admission BMI, kg/m2

25.3 (23.4–28.9)

Admission details

APACHE II score, mean (SD)

21 (10)

Hospital admission duration, days

19 (9–33)

Hospital mortality, %

39

ICU admission duration, days

6 (2–17)

ICU mortality, %

26

Mechanical ventilation, %

55

Sepsis, %

48

Tertiary referral ICU, %

23

Laboratory values

 

Albumin serum at ICU admission, g/L, mean (SD)

25.8 (8.5)

Albumin serum, g/L, mean (SD)

23.3 (8.2)

Creatinine serum at ICU admission, µmol/L

82 (63–159)

Creatinine serum, µmol/L

82 (66–222)

Creatinine clearancea at ICU admission, mL/min/1.73m2, mean (SD)

68 (42)

Creatinine clearancea, mL/min/1.73m2, mean (SD)

66 (42)

Flucloxacillin dose prescribedb

 

6 g per 24 h cont, %

24

9 g per 24 h cont, %

6

12 g per 24 h cont, %

44

1 g q6h, %

6

1 g q4h, %

9

2 g q4h, %

12

  1. Characteristics of the study population at flucloxacillin sampling, unless stated otherwise. Values are expressed as median (interquartile range), unless stated otherwise. Percentages are rounded to whole numbers
  2. APACHE Acute Physiology and Chronic Health Evaluation, BMI body mass index, cont continuous infusion, CKD-EPI Chronic Kidney Disease Epidemiology Collaboration, ICU intensive care unit, q4h 6 times daily, q6h 4 times daily, SD standard deviation
  3. aCreatinine clearance was calculated using the CKD-EPI equation
  4. bThree patients received two different flucloxacillin dosing regimens during ICU admission